全文获取类型
收费全文 | 97682篇 |
免费 | 7946篇 |
国内免费 | 281篇 |
专业分类
耳鼻咽喉 | 1071篇 |
儿科学 | 2556篇 |
妇产科学 | 1579篇 |
基础医学 | 13242篇 |
口腔科学 | 1201篇 |
临床医学 | 10456篇 |
内科学 | 20740篇 |
皮肤病学 | 1067篇 |
神经病学 | 9713篇 |
特种医学 | 3756篇 |
外科学 | 15502篇 |
综合类 | 1240篇 |
一般理论 | 105篇 |
预防医学 | 7749篇 |
眼科学 | 2233篇 |
药学 | 6490篇 |
中国医学 | 98篇 |
肿瘤学 | 7111篇 |
出版年
2023年 | 732篇 |
2022年 | 1135篇 |
2021年 | 2657篇 |
2020年 | 1510篇 |
2019年 | 2454篇 |
2018年 | 2809篇 |
2017年 | 2021篇 |
2016年 | 2138篇 |
2015年 | 2471篇 |
2014年 | 3575篇 |
2013年 | 4699篇 |
2012年 | 7322篇 |
2011年 | 7611篇 |
2010年 | 4150篇 |
2009年 | 3754篇 |
2008年 | 6160篇 |
2007年 | 6416篇 |
2006年 | 5982篇 |
2005年 | 6011篇 |
2004年 | 5426篇 |
2003年 | 5006篇 |
2002年 | 4577篇 |
2001年 | 1214篇 |
2000年 | 1038篇 |
1999年 | 1157篇 |
1998年 | 1030篇 |
1997年 | 797篇 |
1996年 | 694篇 |
1995年 | 603篇 |
1994年 | 592篇 |
1993年 | 574篇 |
1992年 | 678篇 |
1991年 | 616篇 |
1990年 | 586篇 |
1989年 | 587篇 |
1988年 | 496篇 |
1987年 | 476篇 |
1986年 | 469篇 |
1985年 | 451篇 |
1984年 | 430篇 |
1983年 | 356篇 |
1982年 | 400篇 |
1981年 | 375篇 |
1980年 | 290篇 |
1979年 | 304篇 |
1978年 | 288篇 |
1977年 | 239篇 |
1976年 | 205篇 |
1974年 | 223篇 |
1972年 | 189篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
3.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
4.
5.
6.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献7.
8.
Krishna Pillai Javid Akhter Terence C. Chua Mena Shehata Nayef Alzahrani Issan Al-Alem David L. Morris 《Medicine》2015,94(9)
Thermal ablation of liver tumors near large blood vessels is affected by the cooling effect of blood flow, leading to incomplete ablation. Hence, we conducted a comparative investigation of heat sink effect in monopolar (MP) and bipolar (BP) radiofrequency ablation (RFA), and microwave (MW) ablation devices.With a perfused calf liver, the ablative performances (volume, mass, density, dimensions), with and without heat sink, were measured. Heat sink was present when the ablative tip of the probes were 8.0 mm close to a major hepatic vein and absent when >30 mm away. Temperatures (T1 and T2) on either side of the hepatic vein near the tip of the probes, heating probe temperature (T3), outlet perfusate temperature (T4), and ablation time were monitored.With or without heat sink, BP radiofrequency ablated a larger volume and mass, compared with MP RFA or MW ablation, with latter device producing the highest density of tissue ablated. MW ablation produced an ellipsoidal shape while radiofrequency devices produced spheres.Percentage heat sink effect in Bipolar radiofrequency : Mono-polar radiofrequency : Microwave was (Volume) 33:41:22; (mass) 23:56:34; (density) 9.0:26:18; and (relative elipscity) 5.8:12.9:1.3, indicating that BP and MW devices were less affected.Percentage heat sink effect on time (minutes) to reach maximum temperature (W) = 13.28:9.2:29.8; time at maximum temperature (X) is 87:66:16.66; temperature difference (Y) between the thermal probes (T3) and the temperature (T1 + T2)/2 on either side of the hepatic vessel was 100:87:20; and temperature difference between the (T1 + T2)/2 and temperature of outlet circulating solution (T4), Z was 20.33:30.23:37.5.MW and BP radiofrequencies were less affected by heat sink while MP RFA was the most affected. With a single ablation, BP radiofrequency ablated a larger volume and mass regardless of heat sink. 相似文献
9.
10.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献